Table 3. Description of 11 patients with... | American Society of Hematology

Table 3.

Description of 11 patients with hepatitic-variant liver GVHD

Patient	ALP^3-150	AST/ALT^3-150	Total bilirubin/direct bilirubin^3-150	Lobular hepatitis	GVHD outcome	Alive
1	106	506/442	0.8/0.2	N/A	Improved	Yes
2	1262	402/825	2.8/1.4	N/A	Improved	Yes
3	820	438/772	2.6/1.5	Present	Improved	Yes
4	783	307/1148	5.1/4.2	Absent	Worsened	Yes
5	382	226/318	1.1/0.5	Present	Improved	Yes
6	164	1256/245	2.1/1.2	Absent	Worsened	Yes
7	362	80/1495	18.4/17.4	Absent	Worsened	No
8	158	246/411	1.0/0.9	Present	Worsened	No
9	354	383/828	19.2/6.5	Present	Worsened	No
10	1540	918/1540	1.1/0.3	Present	Worsened	Yes
11	239	245/930	9.0/6.9	Absent	Worsened	Yes

Patient	ALP^3-150	AST/ALT^3-150	Total bilirubin/direct bilirubin^3-150	Lobular hepatitis	GVHD outcome	Alive
1	106	506/442	0.8/0.2	N/A	Improved	Yes
2	1262	402/825	2.8/1.4	N/A	Improved	Yes
3	820	438/772	2.6/1.5	Present	Improved	Yes
4	783	307/1148	5.1/4.2	Absent	Worsened	Yes
5	382	226/318	1.1/0.5	Present	Improved	Yes
6	164	1256/245	2.1/1.2	Absent	Worsened	Yes
7	362	80/1495	18.4/17.4	Absent	Worsened	No
8	158	246/411	1.0/0.9	Present	Worsened	No
9	354	383/828	19.2/6.5	Present	Worsened	No
10	1540	918/1540	1.1/0.3	Present	Worsened	Yes
11	239	245/930	9.0/6.9	Absent	Worsened	Yes

N/A indicates not applicable.

Maximum values, upper normal limits: ALP, <127 U/L; AST/ALT, <47/53; total bilirubin/direct bilirubin, < 1.2/0.3.